Epogam evening primrose oil treatment in atopic dermatitis and asthma

Area of Science:

• Dermatology and Nutritional Science
• Pediatric Atopic Diseases Research

Background:

• Essential fatty acids (EFAs) are proposed to benefit atopic diseases.
• Atopic dermatitis is a chronic inflammatory skin condition common in children.
• Asthma frequently co-exists with atopic dermatitis in pediatric populations.

Purpose of the Study:

• To evaluate the efficacy of evening primrose oil (Epogam) supplementation in children with atopic dermatitis.
• To assess the impact of Epogam on co-existing asthma symptoms and general well-being.

Main Methods:

• A 16-week, double-blind, placebo-controlled, parallel-group study involving 58 children with atopic dermatitis.
• Participants received either Epogam evening primrose oil or placebo capsules.
• Data collected included symptom diaries, medication use, peak expiratory flow, and clinician-assessed disease activity.

Main Results:

• Plasma essential fatty acid concentrations significantly increased in the Epogam group.
• Significant improvements in eczema symptoms were observed overall, but without a statistically significant difference between the Epogam and placebo groups.
• No significant therapeutic effects were demonstrated for asthma symptoms or fidgeting.

Conclusions:

• Evening primrose oil supplementation did not show a significant therapeutic advantage over placebo for childhood atopic dermatitis.
• The study found no evidence of benefit for co-existing asthma symptoms or general fidgeting in the treated children.
• Further research may be needed to clarify the role of essential fatty acids in managing atopic diseases.